Specifically, GLP-1 activity has been observed in areas like 8: The hypothalamus, which regulates appetite The brainstem, which connects gut signals to the brain The limbic system, including the nucleus accumbens and ventral tegmental area, which are involved in reward and cravings Through these pathways, GLP-1 medications may: Reduce food cravings and food noise Change how rewarding certain foods feel Lower motivation to seek out highly palatable foods There is also emerging interest in whether these effects extend beyond food
Complaint #2: 'My Skin Feels So Dry and Dull!' We've all heard it: the dry skin lament
This suggests that restoring estrogen levels might help support connective tissue health
Tashiro Y, Sato K, Watanabe T, Nohtomi K, Terasaki M, Nagashima M, Hirano T: A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis
It's not uncommon, especially when first starting, to notice a small, localized reaction at the injection site
Instead, the forward-looking statements contained in this communication are based on our current expectations, assumptions and beliefs concerning future developments and their potential effects on us